Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 03, 2015 1:47 PM ET

Healthcare Equipment and Supplies

Company Overview of Auxogyn, Inc.

Company Overview

Auxogyn, Inc. provides novel scientific and clinically validated solutions to in vitro fertilization clinicians and their patients. The company offers Eeva system, a non-invasive device for the automated prognostic test of embryo development potential. It serves customers worldwide. The company was incorporated in 2008 and is based in Menlo Park, California.

1490 O’Brien Drive

Suite A

Menlo Park, CA 94025

United States

Founded in 2008





Key Executives for Auxogyn, Inc.

Chief Executive Officer
President and Chief Operating Officer
Age: 49
Group Senior Vice President of Commercial Development
Vice President of Medical and Scientific Affairs
Director of Biomedical Research
Compensation as of Fiscal Year 2015.

Auxogyn, Inc. Key Developments

Progyny Appoints Gary Hartonas as Senior Vice President, Commercial Development

Gary Harton, PhD has been appointed as new Group Senior Vice President, Commercial Development by Progyny. Dr. Harton would be playing the role for Progyny's commercial operations, comprising sales, marketing, and customer service operations throughout the products of Fertility, EggBanxx, IVFAdvantage and The Eeva Test, the first and only FDA-cleared test to use time lapse imaging combined with their proprietary algorithm to aid in embryo selection during IVF. Prior to joining, Dr. Harton had a long career in the area of Reproductive Sciences, comprising both laboratory management and IVF practice management posts.

Auxogyn, Inc. Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-12-2014 09:10 AM

Auxogyn, Inc. Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-12-2014 09:10 AM. Venue: Le Parker Meridien, New York, New York, United States.

Auxogyn, Inc. Receives FDA Clearance for its Eeva(TM) System

Auxogyn, Inc. announced that its first product, the Eeva System, received clearance from the U.S. Food and Drug Administration through its de novo classification process, a regulatory pathway for select novel, low- to moderate-risk medical devices that are first-of-a-kind. The Eeva System enables in vitro fertilization (IVF) clinicians to offer the proprietary Eeva Test, which is the first prognostic, non-invasive test that provides objective information regarding embryo development to help optimize treatment plans for their patients.

Similar Private Companies By Industry

Company Name Region
Westone Laboratories, Inc. United States
BÂRRX Medical, Inc. United States
Foster Grant Co., Inc. United States
Biolectron, Inc. United States
Broncus Medical, Inc. United States

Recent Private Companies Transactions

Private Placement
April 21, 2015
March 12, 2015, LLC
Private Placement
March 4, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Auxogyn, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at